Regeneron Pharmaceuticals says fewer than 10 people have been given an experimental antibody cocktail it gave President Trump to fight the coronavirus.
Here & Now‘s Tonya Mosley speaks with STAT reporter Casey Ross about the company’s decision and challenges for other Americans who qualify but can’t access treatment.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org. 9(MDA5MTc0MDI0MDEzMzE4MjI4ODdlOTk4MA004))
/